Mounjaro is approved in Canada for glycemic control in adults with type 2 diabetes, while Zepbound is indicated for chronic weight management in adults who meet specific criteria
To pre-set the desired dosage, simply adjust the dosage adjustment knob to the required dose
The Appetite Revolution Theres a slightly awkward conversation happening in the health world right now
UK considerations NHS and MHRA guidance The UK health authorities have clear positions on weight loss treatments: The NHS offers GLP-1 medications through specialist weight management services for eligible patients MHRA has approved Wegovy, Saxenda, and Mounjaro based on comprehensive safety and efficacy data No GLP-1 patch products have received MHRA approval as weight loss treatments The MHRA has issued warnings about misleading claims in weight loss supplements Cost and access in the UK The financial aspect is a significant consideration for many: NHS provision : Limited availability through specialist weight management services with strict eligibility criteria Private prescriptions : 150-300 monthly, depending on medication and provider Commercial patches : 12-70 monthly, depending on brand and quantity While patches appear less expensive, they lack evidence of effectiveness, making them poor value regardless of price
Both compounds reduce liver fat, but mazdutide provides strong hepatic benefits through its glucagon component without the additional gastrointestinal burden of triple agonism
For non-medical professionals, medical jargon can be difficult to keep straight
